Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa

This publication has 29 references indexed in Scilit:

• Prostaglandins and ulcerative colitis.
  Gut, 1984
• Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
  Gut, 1984
• Soybean lipoxygenase inhibition: Studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine
  European Journal of Clinical Pharmacology, 1984
• Short chain fatty acids in the human colon.
  Gut, 1981
• TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
  The Lancet, 1981
• Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease
  New England Journal of Medicine, 1980
• THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?
  The Lancet, 1980
• Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.
  Gut, 1980
• Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
  Gut, 1980
• AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
  The Lancet, 1977